drugset / Trial / NCT03077555
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception
RandomizedParallel-groupTriple-blindOther
Summary
Quick starting combined oral contraception containing estradiol hemihydrate/nomegestrol acetate is effective to inhibit ovulation in healthy reproductive age women and non-inferiority to combined oral contraception containing ethinyl estradiol/gestodene.
Timeline
- Start
- 2017-01-21
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 1.5 mg | Oral |
| Subject | Gestodene | Small molecule | 75 ug | Oral |
| Subject | Nomegestrol Acetate | Small molecule | 2.5 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 20 ug | Oral |